Avricore Health Inc.
AVCR.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.83% | 110.32% | 99.37% | 58.99% | 16.84% |
| Total Depreciation and Amortization | 4.92% | 24.89% | 44.92% | 76.01% | 128.29% |
| Total Amortization of Deferred Charges | 40.32% | 148.00% | 106.00% | 62.00% | 24.00% |
| Total Other Non-Cash Items | 82.78% | -38.55% | -16.93% | 56.67% | 107.05% |
| Change in Net Operating Assets | -146.09% | -177.36% | -136.96% | 1,753.85% | 260.96% |
| Cash from Operations | 49.97% | 131.26% | 277.90% | 696.94% | 242.39% |
| Capital Expenditure | 82.39% | 53.45% | 51.09% | 39.42% | 16.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.35% | -96.18% | -68.46% | -50.36% | -64.04% |
| Cash from Investing | 80.53% | 51.12% | 49.47% | 38.27% | 15.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 103.76% | -73.15% | -93.91% | -88.11% | -83.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 30.16% | -84.98% | -104.97% | -99.74% | -83.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 344.93% | 181.51% | 108.51% | 105.24% | 76.22% |